Dewei Ye

This researcher studies metabolic and inflammatory diseases, particularly diabetes, diabetic kidney disease, and metabolic dysfunction-associated liver disease (fatty liver disease), often examining how immune cells and specific proteins contribute to organ damage. The work combines laboratory studies in mice, clinical patient cohorts, metabolomics (large-scale measurement of small molecules in blood), and some Traditional Chinese Medicine approaches. Some publications also involve unrelated topics such as education research and biomaterials, suggesting name overlap with other authors or diverse collaborations.

Publication output grew substantially from 2017-2018 (2 papers/year) to a peak around 2020-2022 (9-10 papers/year), then showed a modest decline and fluctuation through 2023-2026, averaging about 7 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026